Related Experiment Video
Updated: Jan 2, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
5.7K
The International/Canadian Hereditary Angioedema Guideline.
Stephen Betschel1, Jacquie Badiou2, Karen Binkley1
11University of Toronto, Toronto, ON Canada.
Summary
This updated guideline offers evidence-based recommendations for managing hereditary angioedema (HAE) globally. It emphasizes individualized care, treatment of attacks, prophylaxis, and comprehensive management strategies for HAE patients worldwide.
Area of Science:
- Medical Guidelines
- Rare Diseases
- Immunology
Background:
- Hereditary angioedema (HAE) causes unpredictable swelling attacks, impacting quality of life and potentially causing mortality.
- Optimal and uniform care for HAE patients is lacking globally, necessitating updated management strategies.
- Existing HAE care models and therapeutic options vary significantly across countries.
Purpose of the Study:
- To provide updated, evidence-based recommendations for the global management of hereditary angioedema (HAE).
- To address acute treatment, prophylaxis, and comprehensive care for HAE patients, including special populations.
- To promote individualized therapy and improve the quality of life for individuals with HAE.
Main Methods:
- Utilized the GRADE system for evidence-based recommendation development.
- Incorporated input from Canadian and international HAE experts and patient groups.
- Expanded scope to include worldwide HAE patient management, diagnosis, and therapies.
Main Results:
- Presents recommendations for HAE attack treatment, short-term and long-term prophylaxis.
- Includes new guidance on diagnosing and treating HAE with normal C1-INH.
- Addresses management in pregnant and pediatric patients, patient associations, and HAE registries.
Conclusions:
- The guideline aims to optimize HAE management and promote individualized care globally.
- It serves as a vital resource for healthcare providers, policymakers, and patient advocates.
- Implementation is expected to improve patient outcomes and quality of life for those with HAE.
Keywords:
Acute attacksGuidelineHereditary angioedemaLong-term prophylaxisPatient registryPediatricsPregnancyQuality of lifeRecommendationsShort-term prophylaxisMore Related Videos
Related Concept Videos
01:26Angina IV: Management
203
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
203
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
325
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
325
01:29Cardiomyopathy V: Interprofessional Care
282
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
282
01:14Myocarditis III: Medical Management
141
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
141
01:21Rheumatic Heart Disease III: Medical Management
247
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
247
01:29Venous Thrombosis III: Interprofessional Care
240
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
240